• No results found

Cover Page The handle http://hdl.handle.net/1887/137444

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle http://hdl.handle.net/1887/137444"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle

http://hdl.handle.net/1887/137444

holds various files of this Leiden University

dissertation.

Author:

Adrichem, R.A. van

Title: Thrombosis prophylaxis after knee arthroscopy or during lower leg cast

immobilization : determining the balance between benefits and risks

(2)

1. The risk of venous thromboembolism is strongly increased in patients with below-knee cast immobili-zation and after arthroscopy of the knee. This risk is further increased for patients who have additional genetic of other acquired risk factors. (this thesis)

2. The large majority of patients with below-knee cast immobilization or knee arthroscopy in the Nether-lands are treated with thrombosis prophylaxis despite insufficient evidence for its effect. (this thesis) 3. In patients with lower leg cast immobilization thromboprophylaxis with daily low molecular weight

heparin during the period of immobilization was not effective for the prevention of symptomatic ve-nous thromboembolism. (this thesis)

4. A prophylactic regimen of low molecular weight heparin for eight days was not effective for the pre-vention of symptomatic venous thromboembolism in patients undergoing knee arthroscopy. (this the-sis)

5. In patients with anterior cruciate ligament reconstruction, routine prophylaxis with low molecular weight heparin in addition to mechanical prophylaxis with a compression stocking did not reduce the incidence venous thromboembolism. (this thesis)

6. The incidence of venous thromboembolism after arthroscopy of the knee, including anterior cruciate ligament reconstruction is low. (Krych AJ, Arthroscopy 2015, Kraus Schmitz J, Bone Joint J. 2019) 7. Patients with lower-limb trauma requiring immobilization have an increased risk of venous

thrombo-embolism. While thromboprophylaxis for all patients seems not effective, targeted thromboprophy-laxis in high risk patients may be an appropriate alternative (Nemeth B, EClinicalMedicine 2020, Mar 20).

8. Environmental risk factors, genetic risk factors and biomarkers can be used for risk prediction for venous thromboembolism in patients with plaster cast immobilization of the lower extremity of after arthroscopy of the knee. Prediction models based on solely environmental risk factors still have good predictive value. (this thesis)

9. There is no consistency in the ratio of asymptomatic and symptomatic venous thrombotic events in high quality VTE prevention trials, highlighting the limitation of including asymptomatic venous thrombosis. (Chan NC, Thromb Haemost 2015)

10. An instrumental variable analysis is a useful alternative to estimate a causal effect by minimizing un-measured confounding when a randomized controlled trial is not feasible (Boef AGC – Ned Tijdschr Geneeskd 2013, Davies NM Epidemiology 2013, Rassen J Clin Epidemiol 2009)

11. Measure what is important; don’t make important what you can measure. (Robert McNamara, be-tween 1961-1968) (Meaning: randomized controlled trials should take relevant endpoints as the pri-mary outcome measure and not (intermediate) endpoints that are easier to obtain, but lack clinical relevance)

12. Andrà tutto bene, everything will be alright (Italian saying and Suzanne C. Cannegieter) (Meaning: although a PhD trajectory comes with a lot of challenges, delays and hick-ups, in the end it all will be all right)

Stellingen behorend bij het proefschrift getiteld

Thrombosis prophylaxis after knee arthroscopy

Referenties

GERELATEERDE DOCUMENTEN

The research described in this thesis was fi nancially supported by the Netherlands Organization for Scientifi c Research (NWO, grant 912-02-036) and was performed at the

The Genetics in Familial Thrombosis (GIFT) study was used in Chapter 3 in the search for novel genetic risk factors for venous thrombosis.. In the GIFT study we collaborated with

To test this hypothesis we genotyped eighteen single nucleotide polymorphisms (SNPs) in these genes, which together tag 25 haplotype groups, in all patients and control subjects of

We found that haplotype 3 (H3) of the gene (IL1RN) coding for the interleukin-1 receptor antagonist (IL-1Ra), the natural inhibitor of the proinfl ammatory cytokine IL-1,

When a novel sequence variation was found, we subsequently investigated the association of this variant with FIX levels and thrombotic risk in a large case-control study on the

Therefore we determined the Marburg I polymorphism in 471 consecutive patients with a fi rst episode of deep venous thrombosis (DVT) and 471 sex- and age-matched healthy controls

In about 40% of GIFT index patients none of the classical genetic risk factors (factor V Leiden, prothrombin 20210A, defi ciencies of protein C, S and antithrombin) was present

In total, 287 aff ected sibling pairs with an objectively confi rmed venous thromboembolism at young age (index patients ≤45 years) were included in the Genetics In Familial